Calstang,

Good question. I believe that unblinding means giving company access to underlying details of treated and placebo patients, not aggregate results/statistical outcomes.

Hopefully Kabonk, ohm, etc can enlighten us, as it seems that humanigen is in a very similar position but with significantly more detail from their interim results.